AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 29 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1,000 | -71.4% | 0.00% | – |
| Q2 2019 | $0 | – | 3,498 | -3.4% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 3,621 | -65.9% | 0.00% | – |
| Q4 2018 | $6,000 | -33.3% | 10,625 | +45.3% | 0.00% | – |
| Q3 2018 | $9,000 | +50.0% | 7,312 | +42.2% | 0.00% | – |
| Q2 2018 | $6,000 | -14.3% | 5,141 | +46.5% | 0.00% | – |
| Q1 2018 | $7,000 | -36.4% | 3,510 | -59.7% | 0.00% | – |
| Q4 2017 | $11,000 | +22.2% | 8,712 | +23.7% | 0.00% | – |
| Q3 2017 | $9,000 | -87.8% | 7,043 | -87.4% | 0.00% | – |
| Q2 2017 | $74,000 | -54.3% | 55,980 | -35.4% | 0.00% | – |
| Q1 2017 | $162,000 | -81.6% | 86,712 | -48.9% | 0.00% | – |
| Q4 2016 | $880,000 | – | 169,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 155,000 | $206,000 | 0.12% |
| Birchview Capital, LP | 128,000 | $170,000 | 0.09% |
| CARL DOMINO INC | 43,273 | $58,000 | 0.07% |
| NORTHERN CAPITAL MANAGEMENT LLC | 106,050 | $141,000 | 0.05% |
| ELEMENT CAPITAL MANAGEMENT LLC | 124,423 | $165,000 | 0.03% |
| Baker Brothers Advisors | 1,618,089 | $2,152,000 | 0.02% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $32,000 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 31,390 | $42,000 | 0.02% |
| WHITE PINE CAPITAL LLC | 20,000 | $27,000 | 0.01% |
| LMR Partners LLP | 112,265 | $149,000 | 0.01% |